{
  "Variants Include": [
    {
      "Gene": "FUS",
      "variants": [
        {
          "HGVS": "NM_001205278:c.1844A>G",
          "cDNA Change": {
            "transcript": "NM_001205278",
            "ref": "A",
            "alt": "G",
            "position": "1844"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "614"
          },
          "Description in input context": "This A>G substitution in exon 16 causes a frameshift and premature stop codon."
        },
        {
          "HGVS": "NM_001205278:c.2325C>T",
          "cDNA Change": {
            "transcript": "NM_001205278",
            "ref": "C",
            "alt": "T",
            "position": "2325"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "L",
            "position": "775"
          },
          "Description in input context": "This C>T substitution in exon 15 causes altered splicing."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Amyotrophic Lateral Sclerosis (ALS)",
    "MONDO": "MONDO:0003713"
  },
  "Experiment Method": [
    {
      "Assay Method": "RT-qPCR",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "ALS-Fibroblasts",
        "Description": "Fibroblasts were obtained from patients diagnosed with sporadic ALS."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001205278:c.1844A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "The mRNA levels for the FUS variant NM_001205278:c.1844A>G were reduced by approximately 60% compared to healthy controls."
        },
        {
          "Variant": "NM_001205278:c.2325C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "altered splicing, reduced protein levels",
          "Result Description": "Splicing analysis revealed the inclusion of a novel intronic sequence due to the NM_001205278:c.2325C>T variant, leading to reduced levels of the full-length FUS protein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were performed on fibroblasts from three independent patients with ALS."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was processed and analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Fibroblasts from healthy donors were used as controls."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "No specific negative control was used in this RT-qPCR assay."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used to compare expression levels."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "mRNA expression within 2 standard deviations of the mean for healthy controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "mRNA expression greater than 2 standard deviations from the mean for healthy controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}